TOG Review (RCOG Journal)

MRCOG Part 2

Gynaecological Oncology

Human papillomavirus-independent cervical cancer and its precursor lesions

Key Statistics

  • 5–11% — Cervical cancers HPV-negative
  • 54% — 5-Yr survival, GAC
  • 42% vs 91% — 5-Yr DSS: GAC vs HPV+ AdenoCa

Don't-miss facts

  1. 5–11% of cervical cancers are HPV-negative on testing – NOT automatically HPV-independent; false negatives occur due to test target loss, low viral load, sampling error, or assay type

  2. Gastric spectrum: LEGH/PGM (benign) → atypical LEGH/GAIS (premalignant) → GAC (malignant); GAC = majority of HPV-independent adenocarcinoma

  3. Red-flag features: profuse watery mucoid discharge, abnormal uterine bleeding, abdominal pain, bulky indurated cervix, multicystic lesion on MRI – assess even if HPV test negative

  4. MRI ‘cosmos pattern’ = highly specific for LEGH; GAC shows solid-cystic components, deep infiltration, restricted diffusion

  5. Peutz–Jeghers syndrome (STK11 mutation) → increased LEGH/GAC risk – needs regular surveillance

  6. GAC 5-year disease-specific survival 42% vs 91% for HPV-associated adenocarcinoma (Karamurzin et al.)

  7. GAC IHC: PAX8+, p16 negative/mosaic, p53 aberrant in ~52%, HNF-1 positive ~90% (can mimic clear cell carcinoma)

  8. Confirmed GAC: manage as HPV-associated cancer but lower threshold for pelvic lymph node assessment (incl. sentinel node mapping) due to higher LVSI/nodal metastasis risk

Figure – WHO 2020 classification logic

Cervical carcinoma

HPV-associated HPV-independent

SCC · usual-type AIS/AdenoCa

Gastric-type Clear cell Mesonephric LEGH → atypical 3–4% of <1% of LEGH/GAIS → GAC AdenoCa AdenoCa

  • NOS adenocarcinoma; + rare HPV-independent SCC (5–7% of cervical SCC)

AIS preinvasive glandular lesion classified by HPV status; preinvasive squamous lesions remain a single HPV-associated category

Simplified WHO 2020 classification logic for cervical carcinoma by HPV association.

AdenoCa = adenocarcinoma; AIS = adenocarcinoma in situ; GAC = gastric adenocarcinoma; GAIS = gastric adenocarcinoma in situ; LEGH = lobular endocervical glandular hyperplasia; NOS = not otherwise specified; SCC = squamous cell carcinoma. PRECURSOR SPECTRUM & SURVIVAL

Benign: LEGH/PGM (5-yr survival 100%) Malignant: GAC (5-yr survival 54%; DSS 42%)

Abbreviation Key

  • HPV — human papillomavirus
  • IECC — International Endocervical Adenocarcinoma Criteria and Classification
  • WHO — World Health Organization
  • MRI — magnetic resonance imaging
  • GAC — gastric-type adenocarcinoma
  • FIGO — International Federation of Gynecology and Obstetrics
  • GAIS — gastric adenocarcinoma in situ
  • PAS — periodic acid Schiff
  • LEGH — lobular endocervical glandular hyperplasia
  • CEA — carcinoembryonic antigen
  • PGM — pyloric gland metaplasia
  • MMR — mismatch repair
  • AIS — adenocarcinoma in situ
  • PD-L1 — programmed death-ligand 1
  • MDA — minimal deviation adenocarcinoma
  • DSS — disease-specific survival
  • NOS — not otherwise specified

Source: Aggarwal IM, Yeo YC, Ng ZY. Human papillomavirus-independent cervical cancer and its precursor lesions. The Obstetrician & Gynaecologist 2023;25:47–58. doi:10.1111/tog.12855

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free